Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: PuraPharm Corporation Limited

Market Cap 163M 20.82M 18.16M 16.82M 15.74M 29.52M 1.96B 29.7M 199M 77.31M 967M 78.17M 76.49M 3.36B P/E 2024
-6.13x
P/E 2025 -4.22x
Enterprise Value 478M 61.05M 53.23M 49.3M 46.15M 86.55M 5.76B 87.08M 585M 227M 2.84B 229M 224M 9.85B EV / Sales 2024
1.42x
EV / Sales 2025 1.5x
Free-Float
34.74%
Yield 2024 *
-
Yield 2025 -
1 day-1.61%
1 week-1.61%
1 month+1.67%
3 months-3.17%
6 months-16.44%
Current year-14.08%
1 week 0.3
Extreme 0.3
0.32
1 month 0.29
Extreme 0.29
0.32
Current year 0.28
Extreme 0.275
0.38
1 year 0.28
Extreme 0.275
0.52
3 years 0.28
Extreme 0.275
1.26
5 years 0.28
Extreme 0.275
2
10 years 0.28
Extreme 0.275
4.39
Manager TitleAgeSince
Chief Executive Officer 65 1998-05-04
Director of Finance/CFO 38 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Chairman 65 1998-05-04
Director/Board Member 60 2011-12-01
Director/Board Member 72 2015-06-11
Date Insider Type Main position Quantity % Market Cap.
22-07-26Other 30,000 0.0076%
22-07-26Other

Chief Executive Officer

30,000 0.0076%
22-05-02Other

Chief Executive Officer

77,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-1.61%-1.61%-33.70%-70.39% 20.82M
+0.34%+0.23%+28.47%+46.67% 18.8B
+0.93%-0.10%+20.19%+64.46% 12.94B
-0.36%-2.25%-30.27%-58.48% 11.36B
+0.14%-3.39%-17.75%+51.96% 9.72B
-1.41%+2.87%+0.07%+62.80% 8.91B
0.00%+1.67%-9.85%-36.35% 8.83B
+0.44%-2.77%+27.50%+217.75% 7.7B
-1.72%+4.09%-8.03% - 6.93B
+0.48%+1.73%+9.54%-32.16% 6.37B
Average -0.28%+0.00%-1.38%+27.36% 9.16B
Weighted average by Cap. -0.03%-0.02%+4.48%+38.54%

Financials

2024 2025
Net sales 382M 48.76M 42.51M 39.37M 36.86M 69.12M 4.6B 69.54M 467M 181M 2.26B 183M 179M 7.86B 336M 42.89M 37.4M 34.63M 32.42M 60.81M 4.05B 61.17M 411M 159M 1.99B 161M 158M 6.92B
Net income -35.44M -4.52M -3.94M -3.65M -3.42M -6.41M -427M -6.45M -43.32M -16.79M -210M -16.97M -16.61M -729M -35.22M -4.49M -3.92M -3.63M -3.4M -6.37M -424M -6.41M -43.06M -16.69M -209M -16.87M -16.51M -725M
Net Debt 327M 41.71M 36.37M 33.68M 31.53M 59.13M 3.94B 59.49M 400M 155M 1.94B 157M 153M 6.73B 315M 40.23M 35.07M 32.48M 30.41M 57.03M 3.8B 57.38M 385M 149M 1.87B 151M 148M 6.49B
Logo PuraPharm Corporation Limited
PuraPharm Corporation Ltd is an investment holding company principally engaged in the concentrated Chinese medicine granule (CCMG) businesses. The Company operates through five business segments. The China CCMG segment is mainly engaged in the production and sales of CCMG products in China. The Hong Kong CCMG segment is mainly engaged in the sales of CCMG products, excluding the sales through self-operated clinics in Hong Kong. The Chinese Healthcare Products segment is mainly engaged in the production and sales of healthcare products in Hong Kong and China. The Clinics segment is mainly engaged in the provision of Chinese medical diagnostic services and sales of CCMG products through self-operated clinics. The Plantation segment is mainly engaged in the plantation and trading of raw Chinese herbs, and the manufacture and sale of traditional Chinese medicine (TCM) decoction pieces.
Employees
441
Date Price Change Volume
26-06-18 0.3050 $ -1.61% 686,000
26-06-17 0.3100 $ 0.00% 1,278,500
26-06-16 0.3100 $ +1.64% 283,000
26-06-15 0.3050 $ -1.61% 536,000
26-06-12 0.3100 $ 0.00% 940,000

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1498 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!